ORGS · As filed with the SEC

Orgenesis cash flow statement, by quarter

The statement as Orgenesis presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.

Consolidated Statements of Cash Flows · USD thousands

USD thousandsQ4 2024†
3 months ended Dec 31, 2024
Q3 2024†
3 months ended Sep 30, 2024
Q2 2024†
3 months ended Jun 30, 2024
Q1 2024
3 months ended Mar 31, 2024
Q4 2023†
3 months ended Dec 31, 2023
Q3 2023†
3 months ended Sep 30, 2023
Q2 2023†
3 months ended Jun 30, 2023
Q1 2023
3 months ended Mar 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:
Profit or Loss(20,376)†(9,266)†(9,366)†(10,005)(6,623)†33,995†15,455†(4,261)
Adjustments required to reconcile net loss to net cash used in operating activities:
Stock-Based Compensation Expense639†1,619†624†31276†76†152†159
Convertible loans induced conversion expenses0†0†——————
Capital gain, net(1,714)†———————
Loss (gain) from deconsolidation of OBI, Korea and Belgium subsidiaries in 2024 (Octomera in 2023)(4,546)†0†0†660†(5,754)†——
Share in losses (income) of associated companies, net——————(3)†2
Share in loss of associated companies, net————182†553†(3)†—
Depreciation Expense461†538†706†381194†191†597†578
Credit loss on convertible loan receivable————0†0†0†—
Credit loss net related to OBI, Korea and Belgium subsidiaries0†0†0†2,049————
Amortization of Intangibles17,646†———————
Effect of exchange differences on inter-company balances775†1,720†152†(200)121†(85)†58†191
Net changes in operating leases1,547†17†32†(8)32†(15)†(20)†(47)
Interest expenses accrued on loans and convertible loans—————543†537†(311)
Change in Contingent consideration(4,906)†81†——————
Interest expense accrued on loans and convertible loans172†174†555†637628†580†574†—
Loss from extinguishment in connection with convertible loan restructuring5,281†0†0†1410†0†0†283
Changes in operating assets and liabilities:
Accounts receivable121†79†4†(74)(19)†(38,220)†(22,801)†(1,613)
Prepaid expenses, other accounts receivable921†(251)†154†1,4382,030†259†326†(2,183)
Inventory0†0†——0†0†(379)†(10)
Other assets—————6†2†2
Other assets47†(3)†0†(1)3†6†2†—
Related parties, net(4)†3†——————
Accounts payable672†515†(2,968)†5021,591†1,034†2,950†(59)
Change in Accrued Liabilities26†(858)†(430)†442747†21†221†69
Change in Accrued Liabilities1,132†176†111†(119)276†12†225†2
Change in Deferred Revenue——————0†36
Change in advance payments and receivables on account of grant, net——————(59)†(81)
Deferred taxes, net0†0†0†(2)0†0†6†3
Net cash used in operating activities(2,098)†(4,630)†(5,907)†(4,441)(502)†(1,181)†(5,914)†(7,240)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property, plants and equipment0†(58)†(1)†(204)0†(300)†(511)†(1,285)
Investment in associated company————(117)†———
Net Cash from Investing Activities0†0†0†139————
Impact to cash resulting from deconsolidation of OBI, Korea and Belgium subsidiaries (see note 20)(6)†0†0†(5)0†0†——
Impact to cash resulting from deconsolidation————0†0†——
Investment in long-term deposits—200†0†20†0†(11)†(22)
Net cash used in investing activities292†142†(1)†(68)(62)†(843)†(1,495)†(1,307)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of shares due to exercise of options and warrants (net of transaction costs)0†28†168†2,360942†1,000†(100)†3,441
Proceeds from Debt Issuance0†0†0†7575†175†0†5,485
Proceeds from Stock Issuance————0†0†——
Proceeds from receipts on account of shares to be allotted———155————
Proceeds from transaction with redeemable non-controlling interest that do not result in a loss of control————0†0†——
Repayment of convertible loans and convertible bonds————0†0†0†(3,000)
Repayment of short and long-term debt25†(106)†(112)†(33)(2)†(3)†(14)†(16)
Proceeds from issuance of loans payable1,390†3,723†640†307210†———
Receipt from Germfree (see note 11a)——5,970†750————
Proceeds from Debt Issuance(16)†———————
Receipt from Germfree (see note 13f)0†———————
Net cash provided by financing activities1,399†4,435†6,511†3,6141,225†1,597†4,886†5,910
NET CHANGE IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH(407)†(53)†603†(895)661†(427)†(2,523)†(2,637)
Effect of Exchange Rate on Cash(28)†19†(12)†(19)29†(11)†19†(1)
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AT BEGINNING OF YEAR1,1221,1565651,4797891,2273,7316,369
CASH, CASH EQUIVALENTS AND RESTRICTED CASH AT END OF YEAR6871,1221,1565651,4797891,2273,731
SUPPLEMENTAL NON-CASH FINANCING AND INVESTING ACTIVITIES
Exchange of convertible loans for equity—0†——————
Net Cash from Operating Activities0†214†——0†(1)†0†753
Increase (decrease) in accounts payable related to purchase of property, plant and equipment————0†0†0†14
Extinguishment in connection with convertible loan restructuring———1410†0†0†287
CASH PAID DURING THE YEAR FOR:
Interest Expense0†0†——0†0†0†785

† Derived: worked out from the filings, not stated in them. A fourth quarter is the 10-K year less the nine months in the third-quarter 10-Q; a quarter of cash flows is year to date less the prior year to date.

As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.